Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
Clinical trial NCT04994717 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04994717
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-02
- Primary completion
- 2029-09-07
- Enrollment
- 303
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.